10.1371/journal.pone.0202575.g002 Sasha Gulati Sasha Gulati Ole Solheim Ole Solheim Sven M. Carlsen Sven M. Carlsen Lise R. Øie Lise R. Øie Heidi Jensberg Heidi Jensberg Agnete M. Gulati Agnete M. Gulati Mattis A. Madsbu Mattis A. Madsbu Charalampis Giannadakis Charalampis Giannadakis Asgeir S. Jakola Asgeir S. Jakola Øyvind Salvesen Øyvind Salvesen Survival following ICH in users and non-users of antithrombotic medications. Public Library of Science 2018 Norwegian Prescription Database antithrombotic medication clopidogrel antithrombotic medication safety RICH incidence rates HR aspirin CI Nationwide pharmacoepidemiological study Background Annual crude ICH rates antithrombotic drugs antithrombotic medication regimens warfarin user Norwegian Patient Registry NCT 2018-08-23 17:57:06 Figure https://plos.figshare.com/articles/figure/Survival_following_ICH_in_users_and_non-users_of_antithrombotic_medications_/7004048 <p>There were significant differences in survival following ICH and in all four subgroups hemorrhagic stroke, subdural hemorrhage, subarachnoid hemorrhage, and traumatic intracranial hemorrhage between users and non-users of antithrombotic medications (all p<0.001). The shaded areas indicate 95% CIs. (A) Survival following any intracranial hemorrhage. (B) Survival following hemorrhagic stroke. (C) Survival following subdural hemorrhage. (D) Survival following subarachnoid hemorrhage. (E) Survival following traumatic intracranial hemorrhage.</p>